Biofrontera (BFRI) Asset Writedowns and Impairment (2020 - 2025)

Biofrontera's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at -$25000.0 for Q4 2025.

• In Q4 2025, Asset Writedowns and Impairment fell 149.02% year-over-year to -$25000.0; the TTM figure through Dec 2025 stood at -$69000.0 (down 142.59% YoY), while the FY2025 annual figure was -$69000.0, down 142.59% from the prior year.
• Asset Writedowns and Impairment was -$25000.0 for Q4 2025 at Biofrontera, down from $13000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $94000.0 in Q3 2023 to a low of -$46000.0 in Q1 2025.
• Historically, Asset Writedowns and Impairment has averaged $17700.0 across 5 years, with a median of $12000.0 in 2024.
• Biggest YoY gain for Asset Writedowns and Impairment was 4650.0% in 2022; the steepest drop was 833.33% in 2022.
• A 5-year view of Asset Writedowns and Impairment shows it stood at -$3000.0 in 2021, then tumbled by 66.67% to -$5000.0 in 2022, then tumbled by 620.0% to -$36000.0 in 2023, then jumped by 241.67% to $51000.0 in 2024, then plunged by 149.02% to -$25000.0 in 2025.
• The last three Asset Writedowns and Impairment figures came in at -$25000.0 (Q4 2025), $13000.0 (Q3 2025), and -$11000.0 (Q2 2025), per Business Quant data.